[Ip-health] FW: Malaysia - Attorney-General Defends Generic Medicines
Before UN Rights Body
3D -> Trade - Human Rights - Equitable Economy
3d@3dthree.org
Tue Feb 6 09:08:01 2007
This is a multi-part message in MIME format.
--
--
[ Picked text/plain from multipart/alternative ]
Geneva, 5 February 2007 -- Malaysia’s Attorney-General Tan Sri ABDUL GANI
has publicly stated his country’s stand "that generic drugs should not be
restricted in any manner," as generics are cheaper than patented medicines.
He made this statement before the UN Committee on the Rights of the Child
(CRC), whose session concluded in Geneva last week. He was speaking in
response to pointed questions from the Committee’s Chair, Jacob E. Doek, who
asked Malaysian governmental representatives how they can ensure that trade
agreements do not affect provision of generic medicines, particularly for
the treatment of HIV/AIDS.
ABDUL GANI specified that bilateral "Free Trade Agreements (FTAs) are
TRIPS-plus" and that Malaysia has not yet agreed to any bilateral trade
agreement with the U.S. Implying that a U.S.-Malaysia FTA could result in
more expensive drugs, Attorney-General ABDUL GANI said that Malaysia is not
going to negotiate on this issue, and added “we are providing the drugs for
free.”
This discussion took place during the CRC's periodic review of the status of
children’s rights in Malaysia. The CRC had before it a note from
non-governmental sources that described the adverse impacts on children’s
rights of the FTA Malaysia is currently negotiating with the U.S.
For more information about the CRC and its role in ensuring trade rules do
not undermine human rights, see the Information Note (text pasted below) or
contact 3D at info@3dthree.org
Best wishes,
The 3D Team
3D --> Trade - Human Rights - Equitable Economy
15, rue des Savoises
1205 Genève
Suisse
T +4122 320 21 21
F +4122 320 69 48
info@3dthree.org
www.3dthree.org <http://www.3dthree.org/>
Malaysia – Attorney-General Defends Generic Medicines
Before UN Rights Body
Information Note Number 6, February 2007
Geneva, 5 February 2007 -- Malaysia’s Attorney-General Tan Sri ABDUL GANI
has
publicly stated his country’s stand "that generic drugs should not be
restricted in any
manner," as generics are cheaper than patented medicines.
He made this statement before the UN Committee on the Rights of the Child,
whose
session concluded in Geneva last week.
ABDUL GANI noted that Malaysia has issued a compulsory license, in
accordance with
World Trade Organization (WTO) rules. He specified that bilateral "Free
Trade
Agreements (FTAs) are TRIPS-plus" and that Malaysia has not yet agreed to
any bilateral
trade agreement with the U.S. Implying that a U.S.-Malaysia FTA could result
in more
expensive drugs, Attorney-General ABDUL GANI said that Malaysia is not going
to
negotiate on this issue, and added “we are providing the drugs for free.”
He was speaking in response to pointed questions from the Committee’s Chair,
Jacob E.
Doek, who asked Malaysian governmental representatives how they can ensure
that trade
agreements do not affect provision of generic medicines, particularly for
the treatment of
HIV/AIDS.
This discussion took place during the Committee on the Rights of the Child’s
periodic
review of the status of children’s rights in Malaysia.1 The Committee had
before it a note
from non-governmental sources, circulated by 3D, that described the adverse
impacts on
children’s rights of the FTA Malaysia is currently negotiating with the U.S.
The Committee on the Rights of the Child is composed of 18 independent
experts of high
moral character and recognized competence in the field of human rights, is
an independent
body that oversees the situation of children in the 193 countries that have
agreed to be
bound by the Convention on the Rights of the Child. The Committee usually
raises
questions relating to the treatment of HIV/AIDS with the countries they
review.
The Committee has played a key role in holding government trade and
Intellectual
Property negotiators accountable to their obligation to uphold human rights.
The
Committee has for instance recommended to the Peruvian government that it
“always take
its human rights obligations into account when negotiating Trade Agreements,
in particular
as to the possible impact of commercial agreements on the full enjoyment of
the right to
health.”
1 For official records of the meeting, and background about the Committee on
the Rights of the Child, see
<www.ohchr.org/english/bodies/crc/crcs44.htm>
The Committee recently urged the Thai government to “ensure that regional
and other free
trade agreements do not have a negative impact on the enjoyment of the right
to health by
children [and specifically,] ensure that such agreements will not negatively
impact the
availability of drugs and medicines for children.”
The Child Rights Committee has made similar recommendations to the
governments of
Botswana, Ecuador, El Salvador, Nicaragua and the Philippines.2 These
Committee
recommendations have been used by groups around the world working to ensure
that trade
rules do not undermine access to affordable medicines.
3D -> Trade - Human Rights - Equitable Economy (3D) is a
non-profit organization based in Geneva, Switzerland,
working to ensure that trade rules are developed and applied
in ways that promote an equitable economy. We believe that
human rights mechanisms such as the Committee on the
Rights of the Child can help attain this objective by reminding
States that international trade rules cannot justify noncompliance
with human rights obligations.
--
[ image001.jpg of type image/jpeg deleted ]
--